| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |